Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.

The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...

Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.

The director of the FDA's Center for Drug Evaluation and Research, Patrizia Cavazzoni, MD, will step down from the role Jan. 18, according to an Endpoints News report. Dr. Cavazzoni joined the FDA ...

With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...

It will be co-led by Patrizia Cavazzoni, director of the FDA's Centre for Drugs Evaluation and Research (CDER), and Centre for Biologics Evaluation and Research (CBER) director Peter Marks.

Dr. Scott Manthei of the Nevada Ear and Sinus Institute has been advising patients against taking drugs like Sudafed for ...

“Based on our review of available data, and consistent with the advice of the advisory committee, we are taking this next step in the process,” said Patrizia Cavazzoni, M.D., director of the ...

WHITE OAK, MD - JULY 20: A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.